Kodiak Gas Services (KGS): Among the Energy Stocks that Lost the Most This Week
A close-up of a large industrial compressor in the oil and gas industry.
Kodiak Gas Services, Inc. (NYSE:KGS) is a leading provider of natural gas contract compression services in the United States, bringing efficiency and reliability to all the major basins.
Kodiak Gas Services, Inc. (NYSE:KGS) has been under pressure over the last week following a drop in the price of natural gas. US natural gas futures have fallen by 7% since June 6, 2025, due to reduced gas flows to LNG export plants amid the ongoing spring maintenance. Key facilities affected include Cameron LNG and Cheniere's Sabine Pass and Corpus Christi, as well as multiple outages at Freeport LNG.
Despite the recent downturn, the share price of Kodiak Gas Services, Inc. (NYSE:KGS) has surged by more than 30% over the last year.
While we acknowledge the potential of KGS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Cheap Energy Stocks to Buy Now and
Disclosure: None.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Abbott Laboratories (NYSE:ABT) shareholders have earned a 9.6% CAGR over the last five years
The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up more than the market average. Unfortunately for shareholders, while the Abbott Laboratories (NYSE:ABT) share price is up 44% in the last five years, that's less than the market return. However, more recent buyers should be happy with the increase of 29% over the last year. Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. Over half a decade, Abbott Laboratories managed to grow its earnings per share at 31% a year. This EPS growth is higher than the 8% average annual increase in the share price. Therefore, it seems the market has become relatively pessimistic about the company. You can see below how EPS has changed over time (discover the exact values by clicking on the image). We know that Abbott Laboratories has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Abbott Laboratories will grow revenue in the future. It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for Abbott Laboratories the TSR over the last 5 years was 58%, which is better than the share price return mentioned above. This is largely a result of its dividend payments! It's good to see that Abbott Laboratories has rewarded shareholders with a total shareholder return of 32% in the last twelve months. That's including the dividend. That's better than the annualised return of 10% over half a decade, implying that the company is doing better recently. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 1 warning sign for Abbott Laboratories you should be aware of. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Why EchoStar Rocketed 56.2% in June
President Trump intervened to try to broker a deal between EchoStar and the FCC. The FCC has been threatening to seize EchoStar's spectrum, saying its rollout of wireless services has been too slow. EchoStar bought some time from having to declare bankruptcy, but still has finalized a deal yet. 10 stocks we like better than EchoStar › Shares of EchoStar Corporation (NASDAQ: SATS) rocketed 56.2% higher in June, according to data from S&P Global Market Intelligence. EchoStar has been embroiled in a controversy with the Federal Communications Commission in the new administration, which has led to missed interest payments and the threat of bankruptcy. However, it appears President Trump intervened on EchoStar's behalf in June, extending the deadline for both parties to agree to a deal. Coming into the month, EchoStar's stock had fallen to distressed levels. That was to be expected; its core satellite TV business is declining, and its efforts to build a 5G mobile network that could rival the other major telecoms was going too slow for the government's liking. That led to a standoff with FCC Chair Brendan Carr, who had threatened to seize EchoStar's spectrum to sell to other companies. Amid the FCC review, EchoStar skipped interest payments on its debt, not knowing whether it would be able to continue building its mobile network. In mid-June, President Trump intervened, calling for a meeting between EchoStar CEO Charlie Ergen and Carr, and apparently telling the parties to come to some sort of amicable deal. After the meeting, EchoStar made $500 million in interest payments it owed before the 30-day grace period was up, buying the company more time to make a deal with the FCC. That being said, EchoStar decided to skip its $114 million interest payment due on July 1, starting another 30-day grace period before the company is technically in default. Given its depressed stock price, it's no surprise to see a big gain when bankruptcy was avoided, and with President Trump seemingly having the company's back. That being said, the company isn't out of the woods. EchoStar still has a massive $26 billion debt load and about $24 billion in net debt, and the success of its potential wireless business is still very much in doubt. As such, it's probably best for investors to stay on the sidelines, especially since the stock has surged to a much higher valuation. Before you buy stock in EchoStar, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and EchoStar wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Billy Duberstein and/or his clients have no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why EchoStar Rocketed 56.2% in June was originally published by The Motley Fool
CNN
an hour ago
- CNN
Will your baby qualify for $1,000 from the Trump administration?
A part of Trump's mega bill includes a national "baby bonds" program that will provide every newborn in the U.S. with $1,000 to get ahead in life. But many critics argue this program does not properly resolve generational child poverty for working families.
